Pro-survival of estrogen receptor-negative breast cancer cells is regulated by a BLT2-reactive oxygen species-linked signaling pathway

Carcinogenesis

Volumn 31, Issue 4, 2009, Pages 543-551

  Choi, Jung A ^a   Lee, Jin Wook ^a   Kim, Hyunju ^a   Kim, Eun Young ^a   Seo, Ji Min ^a   Ko, Jesang ^a   Kim, Jae Hong ^a  

^a Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; LEUKOTRIENE B4 RECEPTOR; PROTEIN BLT2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; UNCLASSIFIED DRUG; 5 ETHYL 2 HYDROXY 4 [6 METHYL 6 (1H TETRAZOL 5 YL)HEPTYLOXY]ACETOPHENONE; LEUKOTRIENE B4; LTB4R2 PROTEIN, HUMAN; NOX1 PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TETRAZOLE DERIVATIVE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION; BREAST TUMOR; CELL CULTURE; CHEMISTRY; FEMALE; METABOLISM; MORTALITY; PHYSIOLOGY;

BREAST NEOPLASMS; CELLS, CULTURED; FEMALE; HUMANS; LEUKOTRIENE B4; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; RECEPTORS, ESTROGEN; RECEPTORS, LEUKOTRIENE B4; SIGNAL TRANSDUCTION; TETRAZOLES;

EID: 77950878441     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp203     Document Type: Article

References (45)

1. Althuis,M.D. et al. (2005) Global trends in breast cancer incidence and mortality 1973-1997. Int. J. Epidemiol., 34, 405-412.
2. Cariou,S. et al. (2000) Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells. Proc. Natl Acad. Sci. USA, 97, 9042-9046.
3. Musgrove,E.A. et al. (1994) Cell cycle control by steroid hormones. Semin. Cancer Biol., 5, 381-389.
4. Brockhoff,G. et al. (2007) Differential impact of Cetuximab, Pertuzumab and Trastuzumab on BT474 and SK-BR-3 breast cancer cell proliferation. Cell Prolif., 40, 488-507.
5. Menard,S. et al. (2000) Role of HER2 gene overexpression in breast carcinoma. J. Cell. Physiol., 182, 150-162.
6. Yarden,Y. et al. (2001) Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol., 2, 127-137.
7. Jordan,V.C. (1995) Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"-20 years as a target for the treatment and prevention of cancer. Breast Cancer Res. Treat., 36, 267-285.
8. Burstein,H.J. (2005) The distinctive nature of HER2-positive breast cancers. N. Engl. J. Med., 353, 1652-1654.
9. Funk,C.D. (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science, 294, 1871-1875.
10. Sampson,A.P. (2000) The role of eosinophils and neutrophils in inflammation. Clin. Exp. Allergy, 30 (suppl. 1), 22-27.
11. Ihara,A. et al. (2007) Blockade of leukotriene B4 signaling pathway induces apoptosis and suppresses cell proliferation in colon cancer. J. Pharmacol. Sci., 103, 24-32.
12. Tong,W.G. et al. (2002) Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Clin. Cancer Res., 8, 3232-3242.
13. Tong,W.G. et al. (2005) LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways. Biochem. Biophys. Res. Commun., 335, 949-956.
14. Rocconi,R.P. et al. (2008) Lipoxygenase pathway receptor expression in ovarian cancer. Reprod. Sci., 15, 321-326.
15. Sveinbjörnsson,B. et al. (2008) Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy. FASEB J., 22, 3525-3536.
16. Yokomizo,T. et al. (1997) A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature, 387, 620-624.
17. Yokomizo,T. et al. (2000) A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J. Exp. Med., 192, 421-432.
18. Yoo,M.H. et al. (2004) Role of the BLT2, a leukotriene B4 receptor, in Ras transformation. Oncogene, 23, 9259-9268.
19. Camp,R.L. et al. (1999) Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer, 86, 2259-2265.
20. Shaw,H.M. et al. (2008) Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology, 53, 345-347.
21. Choi,J.A. et al. (2008) Reactive oxygen species are generated through a BLT2-linked cascade in Ras-transformed cells. Free Radic. Biol. Med., 44, 624-634.
22. Chamulitrat,W. et al. (2003) Association of gp91phox homolog Nox1 with anchorage-independent growth and MAP kinase-activation of transformed human keratinocytes. Oncogene, 22, 6045-6053.
23. Riccardi,C. et al. (2006) Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat. Protoc., 1, 1458-1461.
24. Woo,C.H. et al. (2002) Leukotriene B(4) stimulates Rac-ERK cascade to generate reactive oxygen species that mediates chemotaxis. J. Biol. Chem., 277, 8572-8578.
25. Woo,C.H. et al. (2003) Transepithelial migration of neutrophils in response to leukotriene B4 is mediated by a reactive oxygen species-extracellular signal-regulated kinase-linked cascade. J. Immunol., 170, 6273-6279.
26. Gianni,D. et al. (2008) The involvement of the tyrosine kinase c-Src in the regulation of reactive oxygen species generation mediated by NADPH oxidase-1. Mol. Biol. Cell, 19, 2984-2994.
27. Shin,E.H. et al. (2006) Leukotriene B4 stimulates human monocytederived dendritic cell chemotaxis. Biochem. Biophys. Res. Commun., 348, 606-611.
28. Yokomizo,T. et al. (2001) Hydroxyeicosanoids bind to and activate the low affinity leukotriene B4 receptor, BLT2. J. Biol. Chem., 276, 12454-12459.
29. Jänicke,R.U. et al. (1994) Nuclear c-Myc plays an important role in the cytotoxicity of tumor necrosis factor alpha in tumor cells. Mol. Cell. Biol., 14, 5661-5670.
30. Peters-Golden,M. et al. (2007) Leukotrienes. N. Engl. J. Med., 357, 1841-1854.
31. el-Hakim,I.E. et al. (1990) Leukotriene B4 and oral cancer. Br. J. Oral Maxillofac. Surg., 28, 155-159.
32. Dohadwala,M. et al. (2002) Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion. J. Biol. Chem., 277, 50828-50833.
33. Irons,E. et al. (2008) Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer. Cancer Cell, 13, 91-104.
34. Jiang,W.G. et al. (2003) Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer. Prostaglandins Leukot. Essent. Fatty Acids, 69, 275-281.
35. Jiang,W.G. et al. (2006) Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer. Prostaglandins Leukot. Essent. Fatty Acids, 74, 125-134.
36. Irani,K. et al. (1997) Mitogenic signaling mediated by oxidants in Rastransformed fibroblasts. Science, 275, 1649-1652.
37. Sattler,M. et al. (2000) The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells. J. Biol. Chem., 275, 24273-24278.
38. Vafa,O. et al. (2002) c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogeneinduced genetic instability. Mol. Cell, 9, 1031-1044.
39. Hu,Y. et al. (2005) Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress. J. Biol. Chem., 280, 39485-39492.
40. Mukhopadhyay-Sardar,S. et al. (2000) Antioxidant associated chemoprevention by selenomethionine in murine tumor model. Mol. Cell. Biochem., 206, 17-25.
41. Lam,E.W. et al. (1999) Effects of antioxidant enzyme overexpression on the invasive phenotype of hamster cheek pouch carcinoma cells. Free Radic. Biol. Med., 27, 572-579.
42. Wedgwood,S. et al. (2003) Induction of apoptosis in fetal pulmonary arterial smooth muscle cells by a combined superoxide dismutase/catalase mimetic. Am. J. Physiol. Lung Cell. Mol. Physiol., 285, L305-L312.
43. Clement,M.V. et al. (1996) Superoxide anion is a natural inhibitor of FASmediated cell death. EMBO J., 15, 216-225.
44. Lin,K.I. et al. (1999) Decreased intracellular superoxide levels activate Sindbis virus-induced apoptosis. J. Biol. Chem., 274, 13650-13655.
45. Brar,S.S. et al. (2003) NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. Am. J. Physiol. Cell Physiol., 285, C353-C369.